Wilfried Schroyens

Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirements in multiple myeloma patients: a randomized, controlled trial.

A. Grañena, J. Reiffers, R. Schots, 1999, Blood.